Express Pharma Magazine - January 2021Add to Favorites

Express Pharma Magazine - January 2021Add to Favorites

Go Unlimited with Magzter GOLD

Read Express Pharma along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99 $49.99

$4/month

Save 50% Hurry, Offer Ends in 12 Days
(OR)

Subscribe only to Express Pharma

1 Year $5.49

Save 54%

Buy this issue $0.99

Gift Express Pharma

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Verified Secure
Payment

In this issue

India's Foremost Pharma & Biotech Magazine ~ Blueprint For Progress

CIMS Medica organises Business Excellence Awards 2020

The award ceremony was held at the The Leela Palace Hotel, New Delhi to honour companies who contributed to the growth and development of the healthcare and pharma industry

CIMS Medica organises Business Excellence Awards 2020

1 min

We might need to redefine our approach to drug discovery and approval to be prepared for the future

Hitesh Windlass, MD,Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his organisation’s plans for future growth and more, in an interview with Lakshmpriya Nair

We might need to redefine our approach to drug discovery and approval to be prepared for the future

4 mins

Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials

Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the subsequent learnings in clinical research/trials, emerging trends in this arena and more, in an interaction with Viveka Roychowdhury

Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials

4 mins

BLUEPRINT FOR PROGRESS

Experts and veterans examine and explore strategies for India Pharma Inc to implement the lessons learnt from the COVID-19 pandemic as we enter a new year and a new decade

BLUEPRINT FOR PROGRESS

10+ mins

FDI in brownfield pharma projects - Critical analysis

Arvind Sharma, Partner, Shardul Amarchand Mangaldas & Co informs that the extant regulatory regime for FDI in brownfield projects follows a balanced approach as it safeguards supplies for domestic consumption and ensures foreign investments as well as technological advancement for the pharma sector

FDI in brownfield pharma projects - Critical analysis

4 mins

We help our customers create future-ready pharma manufacturing and biotech facilities

Sanjay Sudhakaran, VP, Digital Energy, Schneider Electric India expands on the value proposition of digital energy systems for the pharma sector, giving some examples of how companies achieved RoI on this investment, in an interaction with Viveka Roychowdhury

We help our customers create future-ready pharma manufacturing and biotech facilities

2 mins

Fighting counterfeiting requires a long-term battle and we need to start somewhere

Globally, incidents of fake, counterfeit pharma products are on the rise and recent cyber attacks on some pharma companies involved in the development of COVID-19 vaccines are raising further alarm. Nakul Pasricha, President, Authentication Solution Providers’ Association (ASPA) talks about the need for a phygital approach to secure supply chain integrity and facilitate easy identification of genuine COVID-19 vaccines, with Usha Sharma

Fighting counterfeiting requires a long-term battle and we need to start somewhere

4 mins

Effective effluent management: Key to tackle AMR

Dr Jyoti Joshi, Head-South Asia,The Center for Disease Dynamics, Economics & Policy (CDDEP); Adjunct Professor,Amity Institute of Public Health emphasises that the government and the pharma industry need to establish strategic partnerships to address the issue of growing AMR due to pharma plant effluents

Effective effluent management: Key to tackle AMR

3 mins

Reverse Brain Drain: Accelerated By Covid-19

Ankit Goyal, Healthcare and Lifesciences Leader India, Heidrick & Struggles finds that leadership hiring is attracting ‘returnee Indians’ in healthcare companies due to growing opportunities in India, and more recently, the impact of the pandemic

Reverse Brain Drain: Accelerated By Covid-19

4 mins

Waters Corporation appoints Pearl S Huang to Board of Directors

She has significant scientific expertise in the discovery of biologics, small molecule and nucleic acid-based therapies, as well as in drug discovery and the development of clinical trials

Waters Corporation appoints Pearl S Huang to Board of Directors

1 min

Read all stories from Express Pharma

Express Pharma Magazine Description:

PublisherThe Indian Express Ltd.

CategoryHealth

LanguageEnglish

FrequencyMonthly

Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994, published by one of the oldest and most respected media group in India, the Indian Express Group. Express Pharma is India’s foremost Pharma & Biotech publication, published in a handy size and an international format, designed for readers convenience. Organized into four sections – Market, Management, Research and Pharma Life, it caters to the information needs of all levels of the pharmaceutical and biotech professionals. EP offers the widest geographic reach, focused business segment coverage and the sure means to reach the senior management and decision makers across the Industry.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View All